Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Annovis Bio (ANVS)

Annovis Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:ANVS
DateTimeSourceHeadlineSymbolCompany
01/04/202413:00GlobeNewswire Inc.Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in HumansAMEX:ANVSAnnovis Bio Inc
20/03/202411:30GlobeNewswire Inc.Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s DiseaseAMEX:ANVSAnnovis Bio Inc
27/02/202413:00GlobeNewswire Inc.Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024AMEX:ANVSAnnovis Bio Inc
14/02/202412:30GlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s DiseaseAMEX:ANVSAnnovis Bio Inc
30/01/202413:00GlobeNewswire Inc.Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s PortfolioAMEX:ANVSAnnovis Bio Inc
24/01/202413:00GlobeNewswire Inc.Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data AnnouncementAMEX:ANVSAnnovis Bio Inc
11/12/202318:00GlobeNewswire Inc.Annovis Bio to Participate in the 139th Yale CEO SummitAMEX:ANVSAnnovis Bio Inc
05/12/202312:30GlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase III Study of Buntanetap in Parkinson’s DiseaseAMEX:ANVSAnnovis Bio Inc
01/12/202312:30GlobeNewswire Inc.Annovis Bio Appoints Andrew Walsh as Vice President FinanceAMEX:ANVSAnnovis Bio Inc
27/11/202312:30GlobeNewswire Inc.Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Original ProjectionsAMEX:ANVSAnnovis Bio Inc
08/11/202322:00GlobeNewswire Inc.Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateAMEX:ANVSAnnovis Bio Inc
12/10/202313:02GlobeNewswire Inc.Annovis Bio Announces Positive Interim Independent Analysis for Statistical Power in Its Alzheimer’s StudyAMEX:ANVSAnnovis Bio Inc
16/06/202321:19Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
30/05/202322:20Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
10/05/202321:35Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ANVSAnnovis Bio Inc
28/04/202313:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:ANVSAnnovis Bio Inc
26/04/202321:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
25/04/202311:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:ANVSAnnovis Bio Inc
03/04/202322:29Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
03/04/202312:53Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
31/03/202314:19Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
08/02/202322:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
20/01/202322:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
20/01/202322:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
20/01/202322:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
20/01/202322:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
20/01/202322:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
06/01/202321:06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
08/11/202221:45Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ANVSAnnovis Bio Inc
12/09/202222:10Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
 Showing the most relevant articles for your search:AMEX:ANVS